The bankruptcy underscores the great risks of investing in many of the companies that have gone public via mergers with ...

23andme says it owns the aggregated genetic data of its customers, meaning it can sell it to the highest bidder ...

Genetic testing company 23andMe (ME) has won court approval to sell its most valuable asset, customer DNA data, despite ...

Me on Sunday filed for bankruptcy in the U.S. after struggling with weak demand for its ancestry testing kits and a 2023 data ...

Me is pursuing a sale after filing for bankruptcy, leading many customers to look into deleting their data from the company.

23andMe bankruptcy underscores the risk of investing in most SPACs ... whose mission is to make acquisitions. Then the SPAC converts its ticker symbol and name over to one matching the name ...

DNA-testing company 23andMe has filed for bankruptcy, which means the future of the company’s vast trove of customer data is ...

Just before the 23andMe SPAC deal closed, the stock belonging to ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets ...

23andMe is going bankrupt — underscoring the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations. When companies opt ...